Hainan Lecheng: what the pilot zone allows, and what the rules say about taking medicines out

1. What the zone actually is

The Boao Lecheng International Medical Tourism Pilot Zone is a defined area in Hainan province operating under arrangements that do not apply elsewhere in mainland China. Its central feature is a narrow exception to national drug and device registration.

The national policy framing was restated in March 2026, when nine ministries led by the Ministry of Commerce issued measures on promoting travel service exports and inbound consumption. Article 10 of that document provides for:

Three limits are visible in that sentence alone, and they are easy to miss on a first reading: clinically urgent need, no equivalent already registered in China, and use by institutions within the zone. Vaccines are expressly carved out.

2. What "licensed access" means in practice

The Chinese term usually rendered as "licensed" or "specially permitted" medicines and devices describes products cleared for use inside the zone under this exception, rather than registered for the national market. Several consequences follow.

• Access is clinical, not commercial. The route is: you become a patient of an institution in the zone, a physician there determines the product is appropriate for your case, and use proceeds under that institution's arrangements. There is no counter at which a product is sold to a visitor.
• The catalogue is specific and it changes. Which products are available at any given time is determined by the zone's arrangements and by which institutions have brought them in. This is not a stable list you can plan around a year ahead.
• Registration status is unchanged elsewhere. A product usable inside Lecheng is not thereby approved for use in the rest of mainland China, and Chinese arrangements have no bearing on its legal status in your own country.

That last point deserves emphasis for anyone travelling. Whether you may lawfully bring a particular medicine into your own country, and in what quantity, is governed by your country's rules, not by China's. This is a question for your own authorities before you travel, not after.

3. Taking medicine out of the zone

This is the provision that draws the most interest and is the most widely misunderstood.

Hainan's drug regulator issued an interim measure in 2020 permitting patients to take a small quantity of clinically urgent imported medicine out of the zone on discharge. That first version covered oral forms only. In August 2022 the Hainan Provincial Medical Products Administration, together with the provincial health commission, issued a replacement, the Administrative Measures for Taking Out and Using Clinically Urgently Needed Imported Drugs in the Boao Lecheng International Medical Tourism Pilot Zone: which made two substantive changes.

Note what did not change. Both versions restrict this to the patient's own use. Official commentary on the 2022 measure describes its purpose as balancing medical safety against genuine need, and specifically as preventing licensed medicines being bulk-purchased, sold on, or given away to others.

4. What we could not verify

We think it is more useful to tell you where our information ends than to present a confident account with soft parts hidden inside it. Everything above is drawn from the policy text and from official summaries. The following, we could not confirm against a primary source, and you should not plan around it without checking directly.

5. Four things this is not

1. Not a pharmacy or a purchase channel. You cannot travel to Hainan and buy an unregistered medicine. Access follows a clinical decision made by an institution that has taken you on as a patient.
2. Not a route around your own country's rules. Whether a medicine may lawfully enter your country, and in what quantity, is your country's question. Nothing in the Chinese arrangement addresses it.
3. Not a guarantee that a particular product is available. The catalogue is specific, institution-dependent and subject to change.
4. Not something an agency can arrange for you. Any intermediary offering to obtain or carry these medicines is offering something outside the rules as written, and outside what we will ever do.

6. What to ask the institution

If your situation genuinely points here, these are the questions worth putting directly to an institution in the zone, in writing, before making any travel plans.

• Is the specific product available at your institution at present, and under what conditions?
• What clinical criteria would I need to meet, and what records would you need to see first?
• If treatment continues after discharge, is this product within the dosage forms eligible to be taken out of the zone?
• What is the filing procedure, what quantity would be involved, and what would I be required to do afterwards, follow-up visits, reporting, traceability records?
• What are the total costs, and how are they billed?
• Do you have experience with non-resident foreign patients, and does anything differ in that case?

Separately, and before any of the above: ask your own country's medicines regulator or customs authority whether the product may lawfully be brought in, and in what quantity. It is the question most likely to change the answer, and the one most often left until last.